SHOX2, a significant transcriptional regulator in multiple genetic disorders, has been verified to be a powerful biomarker for the evaluation and diagnosis of a wide variety of cancers, including lung cancer [24, 25]. The gene discussed is SHOX2; the disease is lung carcinoma.